{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:22:49Z","timestamp":1790803369567,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jpba.2023.115709","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T11:23:38Z","timestamp":1693999418000},"page":"115709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The identification of key metabolites and mechanisms during isoniazid\/rifampicin-induced neurotoxicity and hepatotoxicity in a mouse model by HPLC-TOF\/MS-based untargeted urine metabolomics"],"prefix":"10.1016","volume":"236","author":[{"given":"Yanqing","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1685-6914","authenticated-orcid":false,"given":"Xiaoyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115709_bib1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s41256-021-00227-x","article-title":"Addressing constraints to informal providers' involvement in tuberculosis control: a qualitative study of patent medicine dealers and tuberculosis programme managers","volume":"6","author":"Onah","year":"2021","journal-title":"Glob. Health Res. Policy"},{"key":"10.1016\/j.jpba.2023.115709_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12879-022-07364-9","article-title":"Risk factors on healthcare-associated infections among tuberculosis hospitalized patients in China from 2001 to 2020: a systematic review and meta-analysis","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jpba.2023.115709_bib3","first-page":"691","article-title":"Nosocomial infection surveillance in a tuberculosis specialized hospital in China","volume":"30","author":"Xie","year":"2017","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.jpba.2023.115709_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/crj.13276","article-title":"Drug safety in hospitalized patients with tuberculosis: drug interactions and adverse drug effects","volume":"15","author":"Noor","year":"2021","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.jpba.2023.115709_bib5","article-title":"Association of adverse drug reaction to anti-tuberculosis medication with quality of life in patients in a tertiary referral hospital","volume":"53","author":"Valadares","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.jpba.2023.115709_bib6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpba.2023.115709_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1021\/acs.chemrestox.8b00066","article-title":"Integrated metabolomics and proteomics approach to identify metabolic abnormalities in rats with dioscorea bulbifera rhizome-induced hepatotoxicity","volume":"31","author":"Zhao","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jpba.2023.115709_bib8","doi-asserted-by":"crossref","first-page":"11433","DOI":"10.1038\/s41598-017-11759-z","article-title":"Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach","volume":"7","author":"Chang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2023.115709_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrneph.2017.30","article-title":"Metabolomics for clinical use and research in chronic kidney disease","volume":"13","author":"Hocher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.jpba.2023.115709_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/org.24322","article-title":"Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets","volume":"9","author":"Wettersten","year":"2013","journal-title":"Organogenesis"},{"key":"10.1016\/j.jpba.2023.115709_bib11","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4155\/bio.09.142","article-title":"Metabolomics for early detection of drug-induced kidney injury: review of the current status","volume":"1","author":"Boudonck","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2023.115709_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","journal-title":"Mass. Spectrom. Rev."},{"key":"10.1016\/j.jpba.2023.115709_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/978-3-030-15950-4_38","article-title":"Analytical methods for mass spectrometry-based metabolomics studies","volume":"1140","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jpba.2023.115709_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jchromb.2009.01.007","article-title":"Normalization strategies for metabonomic analysis of urine samples","volume":"877","author":"Warrack","year":"2009","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life. Sci."},{"key":"10.1016\/j.jpba.2023.115709_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12916-021-02189-w","article-title":"Isoniazid or rifampicin preventive therapy with and without screening for subclinical TB: a modeling analysis","volume":"19","author":"Kendall","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/j.jpba.2023.115709_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.toxlet.2018.05.032","article-title":"Isoniazid-induced hepatotoxicity and neurotoxicity in rats investigated by (1)H NMR based metabolomics approach","volume":"295","author":"Ruan","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jpba.2023.115709_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.talanta.2019.05.039","article-title":"Urinary metabolomic signature of muscle-invasive bladder cancer: a multiplatform approach","volume":"202","author":"Jacyna","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.jpba.2023.115709_bib18","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.3390\/molecules26164990","article-title":"Untargeted metabolomics in forensic toxicology: a new approach for the detection of fentanyl intake in urine samples","volume":"26","author":"Amante","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115709_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/metabo12100981","article-title":"Mechanisms of Ardisia japonica in the treatment of hepatic injury in rats based on LC-MS metabolomics","volume":"12","author":"Fu","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2023.115709_bib20","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7163\/ab7f9d","article-title":"A mechanistic study and review of volatile products from peroxidation of unsaturated fatty acids: an aid to understanding the origins of volatile organic compounds from the human body","volume":"14","author":"Ratcliffe","year":"2020","journal-title":"J. Breath. Res"},{"key":"10.1016\/j.jpba.2023.115709_bib21","first-page":"3985","article-title":"Multi-omics characterization of the unsaturated fatty acid biosynthesis pathway in colon cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.jpba.2023.115709_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2020.152366","article-title":"Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF\/MS-based non-targeted urine and kidney metabolomics approach in rats","volume":"431","author":"Qu","year":"2020","journal-title":"Toxicology"},{"key":"10.1016\/j.jpba.2023.115709_bib23","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1021\/acs.jafc.9b00942","article-title":"Protective effects of functional amino acids on apoptosis, inflammatory response, and pulmonary fibrosis in lipopolysaccharide-challenged mice","volume":"67","author":"Ma","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jpba.2023.115709_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108815","article-title":"Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy","volume":"314","author":"Liu","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jpba.2023.115709_bib25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3389\/fimmu.2019.01565","article-title":"Immunoregulatory interplay between arginine and tryptophan metabolism in health and disease","volume":"10","author":"Mondanelli","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jpba.2023.115709_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/metabo10050208","article-title":"Tryptophan metabolism, inflammation, and oxidative stress in patients with neurovascular disease","volume":"10","author":"Hajsl","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.jpba.2023.115709_bib27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3390\/molecules23061490","article-title":"Metabolomic analysis of biochemical changes in the serum and urine of Freund's adjuvant-induced arthritis in rats after treatment with silkworm excrement","volume":"23","author":"Zheng","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2023.115709_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.989060","article-title":"Metabolome, microbiome, and gene expression alterations in the colon of newborn piglets with intrauterine growth restriction","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jpba.2023.115709_bib29","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1039\/C7RA12451A","article-title":"Exploring the biomarkers and therapeutic mechanism of kidney-yang deficiency syndrome treated by You-gui pill using systems pharmacology and serum metabonomics","volume":"8","author":"Chen","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpba.2023.115709_bib30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/ijc.34287","article-title":"Urine biomarkers enable pancreatic cancer detection up to 2\u0393\u00c7\u00ebyears before diagnosis","volume":"152","author":"Debernardi","year":"2022","journal-title":"Int. J. Cancer"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523004788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523004788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:31:50Z","timestamp":1760002310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523004788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"alternative-id":["S0731708523004788"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115709","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The identification of key metabolites and mechanisms during isoniazid\/rifampicin-induced neurotoxicity and hepatotoxicity in a mouse model by HPLC-TOF\/MS-based untargeted urine metabolomics","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115709"}}